The risk of mortality among older adults hospitalized with influenza was significantly lower among those who received oseltamivir vs no antiviral therapy.

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

For adults 65 years and older who face higher hospitalization risks from both viruses, the combination vaccine triggered stronger immune responses against three clinically relevant influenza ...

It commonly causes tens of thousands of hospitalizations in children," said Dr. Hopkins. "The primary benefit of the Influenza vaccination is reducing the risk for hospitalization for severe illness.